Table 5 Stepwise regression analysis for incident diabetic patients after dialysis with 5-year survival rate, n = 335
Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
HR (95% CI) | P-value | aHR (95% CI) | P-value | |
Age > 60 years | 2.52 (1.67–3.79) | < 0.001 | 2.35 (1.56–3.55) | < 0.001 |
Gender—male | 1.40 (0.98–2.00) | 0.068 | ||
Anti-diabetic drug use | ||||
OHA | 1 | |||
Insulin | 1.63 (1.14–2.33) | 0.008 | 1.41 (0.98–2.02) | 0.068 |
Region | ||||
Northern | 1 | |||
Central | 1.23 (0.80–1.89) | 0.900 | ||
Southern/Eastern | 0.94 (0.63–1.52) | 0.398 | ||
Insured premium (NT$) | ||||
< 15,840 | 1 | |||
15,840–25,000 | 0.78 (0.51–1.20) | 0.254 | ||
> 25,000 | 0.87 (0.55–1.38) | 0.543 | ||
Urbanization | ||||
Urban | 1 | |||
Sub-urban | 0.75 (0.50–1.12) | 0.157 | ||
Rural | 0.84 (0.47–1.62) | 0.565 | ||
Hospital characteristics | ||||
Medical center | 1.19 (0.81–1.76) | 0.378 | ||
Region/others | 1 | |||
Number of admissions during the 12 months leading up to dialysis | ||||
0–1 | 1 | |||
> 1 | 1.59 (1.05–2.43) | 0.031 | ||
Dialysis modality | ||||
Peritoneal dialysis | 1 | |||
Hemodialysis | 1.24 (0.54–2.81) | 0.614 | ||
Comorbidity | ||||
Hypertension | 1.22 (0.85–1.75) | 0.275 | ||
Hyperlipidemia | 0.43 (0.23–0.81) | 0.008 | 0.45 (0.24–0.85) | 0.014 |
Gout | 0.85 (0.50–1.46) | 0.557 | ||
Congestive heart failure | 1.27 (0.85–1.89) | 0.239 | ||
Cerebrovascular accident | 2.03 (1.28–3.22) | 0.003 | 2.04 (1.27–3.29) | 0.003 |
COPD | 1.92 (1.18–3.14) | 0.009 | 1.68 (1.03–2.76) | 0.039 |
Chronic liver disease | 1.00 (0.47–2.15) | 0.998 | ||
Malignancy | 1.65 (0.98–2.80) | 0.061 | ||
ACEI/ARB use | 0.68 (0.48–0.97) | 0.033 | ||
Lipid-lowering drugs use | 0.50 (0.33–0.76) | 0.001 | 0.66 (0.43–1.02) | 0.060 |